Development and evaluation of CmeC subunit vaccine against Campylobacter jejuni

Journal of Vaccines and Vaccination

Volumn 1, Issue 3, 2010, Pages

  Zeng, Ximin ^a   Xu, Fuzhou ^a   Lin, Jun ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Campylobacter jejuni; Multidrug efflux pump; Subunit vaccine

Indexed keywords

EID: 84879824324     PISSN: None     EISSN: 21577560     Source Type: Journal    
DOI: 10.4172/2157-7560.1000112     Document Type: Article

References (46)

1. Olson CK, Ethelberg S, Pelt WV, Tauxe RV (2008) Epidemiology of Campylobacter jejuni infections in industrialized countries. p. 163-189. In Nachamkin I, Szymanski CM and Blaser MJ (ed.), Campylobacter, 3rd ed., ASM Press, Washington, DC.
2. Rees JH, Soudain SE, Gregson NA, Hughes RA (1995) Campylobacter jejuni Infection and Guillain-Barre syndrome. N Engl J Med 333(21): 1374-1379.
3. Nachamkin I, Allos BM, Ho T (1998) Campylobacter species and Guillain-Barre Syndrome. Clin Microbiol Rev 11: 555-567.
4. Young KT, Davis LM, Dirita VJ (2007) Campylobacter jejuni: molecular biology and pathogenesis. Nat Rev Microbiol 5: 665-679.
5. Engberg J, Aarestrup FM, Taylor DE Gerner-Smidt P, Nachamkin I (2001) Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. Emerg Infect Dis 7: 24-34.
6. Projan SJ (2003) Why is big Pharma getting out of antibacterial drug discovery?. Curr Opin Microbiol 6: 427-430.
7. Lin J (2009) Novel approaches for Campylobacter control in poultry. Foodborne Pathog Dis 6: 755-765.
8. de Zoete MR, van Putten JP, Wagenaar JA (2007) Vaccination of chickens against Campylobacter. Vaccine 25: 5548-557.
9. Jagusztyn-Krynicka EK, Laniewski P, Wyszynska A (2009) Update on Campylobacter jejuni vaccine development for preventing human campylobacteriosis. Expert Rev Vaccines 8: 625-645.
10. Lin J, Akiba M, Sahin O, Zhang Q (2005) CmeR functions as a transcriptional repressor for the multidrug efflux pump CmeABC in Campylobacter jejuni. Antimicrob Agents Chemother 49: 1067-1075.
11. Lin J, Michel LO, Zhang Q (2002) CmeABC functions as a multidrug efflux system in Campylobacter0 jejuni. Antimicrob Agents Chemother 46: 2124-2131.
12. Lin J, Sahin O, Michel LO, Zhang Q (2003) Critical role of multidrug efflux pump CmeABC in bile resistance and in vivo colonization of Campylobacter jejuni. Infect Immun 71: 4250-4259.
13. Lin J, Cagliero C, Guo B, Barton YW, Maurel MC, et al. (2005) Bile salts modulate expression of the CmeABC multidrug efflux pump in Campylobacter jejuni. J Bacteriol 87: 7417-7424.
14. Stintzi A, Marlow D, Palyada K, Naikare H, Panciera R, et al. (2005) Use of genome5 wide expression profiling and mutagenesis to study the intestinal lifestyle of Campylobacter jejuni. Infect Immun 73: 1797-1810.
15. Martinez A, Lin J (2006) Effect of an efflux pump inhibitor on the function of the multidrug efflux pump CmeABC and antimicrobial resistance in Campylobacter. Foodborne Pathog Dis 3: 393-402.
16. Lin J, Martinez A (2006) Effect of efflux pump inhibitors on bile resistance and in vivo colonization of Campylobacter jejuni. J Antimicrob Chemother 58: 966-972.
17. Xu F, Zeng X, Haigh RD, Ketley JM, Lin J (2010) Identification and Characterization of a New Ferric Enterobactin Receptor, CfrB, in Campylobacter. J Bacteriol 192: 4425-4435.
18. Akiba M, Lin J, Barton YW, Zhang Q (2006) Interaction of CmeABC and CmeDEF in conferring antimicrobial resistance and maintaining cell viability in Campylobacter jejuni. J Antimicrob Chemother 57: 52-60.
19. Graslund S, Nordlund P, Weigelt J, Hallberg BM, Bray J, et al. (2008) Protein production and purification. Nat Methods 5: 135-146.
20. Wyszynska A, Raczko A, Lis M, Jagusztyn-Krynicka EK (2004) Oral immunization of chickens with avirulent Salmonella vaccine strain carrying C. jejuni 72Dz/92 cjaA gene lelicits specific humoral immune response associated with protection against challenge with wild-type Campylobacter. Vaccine 22: 1379-1389.
21. Sahin O, Zhang Q, Meitzler JC, Harr BS, Morishita TY, et al. (2001) Prevalence, antigenic specificity, and bactericidal activity of poultry anti-Campylobacter maternal antibodies. Appl Environ Microbiol 67: 3951-3957.
22. Andersen C, Koronakis E, Bokma E, Eswaran J, Humphreys D, et al. (2002) Transition to the open state of the TolC periplasmic tunnel entrance. Proc Natl Acad Sci U S A 99: 11103-11108.
23. Harjes S, Scheidig A, Bayer P (2004) Expression, purification and crystallization of human 3'-phosphoadenosine-5'-phosphosulfate synthetase 1. Acta Crystallogr D Biol Crystallogr 60: 350-352.
24. Sahin O, Luo N, Huang S, Zhang Q (2003) Effect of Campylobacter-specific maternal antibodies on Campylobacter jejuni colonization in young chickens. Appl Environ Microbiol 69: 5372-5379.
25. Fakhr MK, Logue CM (2007) Sequence variation in the outer membrane protein37 encoding gene cmeC, conferring multidrug resistance among Campylobacter jejuni and Campylobacter coli strains isolated from different hosts. J Clin Microbiol 45: 3381-3383.
26. de Marco A (2007) Protocol for preparing proteins with improved solubility by co40 expressing with molecular chaperones in Escherichia coli. Nat Protoc 2: 2632-2639.
27. de Marco A (2006) Two-step metal affinity purification of double-tagged (NusAHis6) fusion proteins. Nat Protoc 1: 1538-1543.
28. de Marco A, Deuerling E, Mogk A, Tomoyasu T, Bukau B (2007) Chaperonebased procedure to increase yields of soluble recombinant proteins produced in E. coli. BMC Biotechnol 12: 7-32.
29. Zhang Q, Meitzler JC, Huang S, Morishita T (2000) Sequence polymorphism, predicted secondary structures, and surface-exposed conformational epitopes of Campylobacter major outer membrane protein. Infect Immun 68: 5679-5689.
30. Conlan AJ, Coward C, Grant AJ, Maskell DJ, Gog JR (2007) Campylobacter jejuni colonization and transmission in broiler chickens: a modelling perspective. J R Soc Interface 4: 819-829.
31. Monteiro MA, Baqar S, Hall ER, Chen YH, Porter CK, et al. (2009) Capsule polysaccharide conjugate vaccine against diarrheal disease caused by Campylobacter jejuni. Infect Immun 77: 1128-1136.
32. Rice BE, Rollins DM, Mallinson ET, Carr L, Joseph SW (1997) Campylobacter jejuni in broiler chickens: colonization and humoral immunity following oral vaccination and experimental infection. Vaccine 15: 1922-1932.
33. Wilkinson J, Rood D, Minior D, Guillard K, Darre M, et al. (2003) Immune response to a mucosally administered aflatoxin B1 vaccine. Poult Sci 82: 1565-1572.
34. Lapa JA, Sincock SA, Ananthakrishnan M, Porter CK, Cassels FJ, et al. (2008) Randomized clinical trial assessing the safety and immunogenicity of oral microencapsulated enterotoxigenic Escherichia coli surface antigen 6 with or without heat-labile enterotoxin with mutation R192G. Clin Vaccine Immunol 15: 1222-1228.
35. Yuan L, Iosef C, Azevedo MS, Kim Y, Qian Y, et al. (2001) Protective immunity and antibody-secreting cell responses elicited by combined oral attenuated Wa human rotavirus and intranasal Wa 2/6-VLPs with mutant Escherichia coli heatlabile toxin in gnotobiotic pigs. J Virol 75: 9229-6238.
36. Tribble DR, Baqar S, Thompson SA (2008) Development of a Human Vaccine. Pages: 429-444. In I. Nachamkin, C. M. Szymanski, and M. J. Blaser (ed.), Campylobacter, 3rd ed. ASM Press, Washington, DC.
37. Sinha VR, Singla AK, Wadhawan S, Kaushik R, Kumria R, et al. (2004) Chitosan microspheres as a potential carrier for drugs. Int J Pharm 274: 1-33.
38. Arca HC, Gunbeyaz M, Senel S (2009) Chitosan-based systems for the delivery of Vaccine antigens. Expert Rev Vaccines 8: 937-953.
39. Kwon YM, Cox MM, Calhoun LN (2007) Salmonella-based vaccines for infectious diseases. Expert Rev Vaccines 6: 147-152.
40. Lomovskaya O, Warren MS, Lee A, Galazzo J, Fronko R, et al. (2001) Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas 25 aeruginosa: novel agents for combination therapy. Antimicrob Agents Chemother 45: 105-116.
41. Lomovskaya O and Watkins W (2001) Inhibition of efflux pumps as a novel approach to combat drug resistance in bacteria. J Mol Microbiol Biotechnol 3: 225-2236.
42. Ryan BM, Dougherty TJ, Beaulieu D, Chuang J, Dougherty BA, et al. (2001) Efflux in bacteria: what do we really know about it? Expert Opin Investig Drugs 10: 1409-1422.
43. Huang S, Luangtongkum T, Morishita TY, Zhang Q, (2005) Molecular typing of Campylobacter strains using the cmp gene encoding the major outer membrane protein. Foodborne Pathog Dis 2: 12-23.
44. Zeng X, Xu F and Lin J (2009) Molecular, antigenic, and functional characteristics of ferric enterobactin receptor CfrA in Campylobacter jejuni. Infect Immun 77: 5437-5448.
45. Parkhill J, Wren BW, Mungall K, Ketley JM, Churcher C, et al. (2000) The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature 403: 665-668.
46. Black RE, Levine MM, Clements ML, Hughes TP, Blaser MJ (1988) Experimental pylobacter jejuni infection in humans. J Infect Dis 157: 472-479.